Expression of tumor necrosis factor alpha and matrix metalloproteinase-9 in surgically induced necrotizing scleritis

Ophthalmic Research

Volumn 38, Issue 2, 2006, Pages 66-70

  Seo, Kyoung Yul ^a   Lee, Hyung Keun ^b   Kim, Eung Kweon ^a   Lee, Joon H ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

MMP 9; Necrotizing scleritis; TNF

Indexed keywords

CORTICOSTEROID; GELATINASE B; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ALLOGRAFT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LACRIMAL FLUID; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERITIS;

AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; SCLERA; SCLERITIS; TEARS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644659336     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090010     Document Type: Article

References (22)

1. O'Donoghue E, Lightman S, Tuft S, Watson P: Surgically induced necrotising sclerokeratitis (SINS): precipitating factors and response to treatment. Br J Ophthalmol 1992;76:17-21.
2. Alsagoff Z, Tan DT, Chee SP: Necrotising scleritis after bare sciera excision of pterygium. Br J Ophthalmol 2000;84:1050-1052.
3. Scott JA, Clearkin LG: Surgically induced diffuse scleritis following cataract surgery. Eye 1994;8:292-297.
4. Sainz de la Maza M, Foster CS: Necrotizing scleritis after ocular surgery: a clinicopathologic study. Ophthalmology 1991;98:1720-1726.
5. Oh JH, Kim JC: Repair of scleromalacia using preserved scleral graft with amniotic membrane transplantation. Cornea 2003;22:288-293.
6. Jones DT, Monroy D, Pflugfelder SC: A novel method of tear collection: comparison of glass capillary micropipettes with porous polyester rods. Cornea 1997;16:450-458.
7. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
8. Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D: Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 1997;150:653-666.
9. Prada J, Noelle B, Baatz H, Hartmann C, Pleyer U: Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol 2003;87:548-550.
10. Oshida T, Iwata M, Sakimoto T, Sawa M: Tumor necrosis factor-alpha in tears of patients with Sjögren syndrome. Nippon Ganka Gakkai Zasshi 2004;108:297-301.
11. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC: Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001;73:449-459.
12. Sakimoto T, Shoji J, Sawa M: Active form of gelatinases in tear fluid in patients with corneal ulcer or ocular burn. Jpn J Ophthalmol 2003;47:423-426.
13. Xue ML, Wakefield D, Willcox MD, Lloyd AR, Di Girolamo N, Cole N, Thakur A: Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci 2003;44:2020-2025.
14. Kernacki KA, Chunta JL, Barrett RP, Hazlett LD: TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction. Exp Eye Res 2004;78:1155-1162.
15. Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC: Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004;45:4302-4311.
16. Riley GP, Harrall RL, Watson PG, Cawston TE, Hazleman BL: Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 1995;9:703-718.
17. Dursun D, Kim MC, Solomon A, Pflugfelder SC: Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol 2001;132:8-13.
18. Diaz-Valle D, Miguelez Sanchez R, Fernandez Espartero MC, Pascual Allen D: Treatment of refractory anterior diffuse scleritis with infliximab. Arch Soc Esp Oftalmol 2004;79:405-408.
19. Cazabon S, Over K, Butcher J: The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye 2005;19:222-224.
20. Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D: Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 2004;111:352-356.
21. Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM: Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol 2004;138:925-930.
22. Foroozan R, Buono LM, Sergott RC, Savino PJ: Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 2002;120:985-987.